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The present study reports for the first time that enhanced oxidative stress exhibited by vascular smooth muscle cells from spontaneously hypertensive rats through the activation of c-Src and growth factor receptors increases the activity of MAP kinase and contributes to enhanced expression of Gq␣ and PLC␤1 proteins and resultant vascular smooth muscle cell hypertrophy.
HYPERTENSION IS ASSOCIATED with vascular remodeling characterized by enhanced media-to-lumen ratio in arteries (29) and is attributed to hyperproliferation and hypertrophy of vascular smooth muscle cells (VSMCs) (43) . Several hormones including ANG II that increase blood pressure are also implicated in vascular remodeling by promoting VSMC proliferation and hypertrophy (4, 7, 10) through the activation of several signaling mechanisms including adenylyl cyclase/cAMP, phosphatidyl inositide, MAP kinase, and tyrosine kinase pathways (17, 19, 38) . These signaling mechanisms are regulated by guanine nucleotide regulatory proteins (G proteins). The G proteins are heterotrimeric proteins composed of three subunits (␣, ␤, and ␥). Two G proteins, stimulatory (Gs␣) and inhibitory (Gi␣), regulate adenylyl cyclase activity and cAMP levels, whereas the Gq␣ family of G proteins is subdivided into Gq␣, G11␣, G14␣, and G16␣. The activation of Gq␣ by a G proteincoupled receptor (GPCR) stimulates phospholipase C-␤ (PLC-␤), which hydrolyzes inositol biphosphate (PIP2) and produces inositol 1,4,5-trisphosphate [Ins (1, 4, 5) P3] (IP 3 ) and diacylglycerol (DAG) (22) and activates PKC (8, 42) .
The implication of Gq␣ and MAPK/phosphatidylinositol 3-kinase signaling has been shown in VSMC hypertrophy induced by vasoactive peptides in A10 VSMC (32) . Gq␣ protein and associated signaling has also been shown to be involved in ANG II-induced VSMC hypertrophy (38) . We have further shown that VSMCs from 16-wk-old and not from 12-wk-old SHRs exhibit enhanced expression of Gq␣ and PLC␤1 proteins, which contribute to VSMC hypertrophy through the activation of MAP kinase signaling pathway (4) . The enhanced levels of Gq␣ and PLC␤1 proteins in VSMCs from SHRs were shown to be attributed to the enhanced levels of endogenous ANG II and endothelin-1 (ET-1) (4).
The generation of reactive oxygen species (ROS) that increases oxidative stress has been implicated in the pathogenesis of many vascular diseases, such as hypertension, diabetes, atherosclerosis, and vascular remodeling (6, 16, 23) . The contribution of oxidative stress in hyperglycemia-induced enhanced expression of Gq␣ protein in VSMCs has been reported (14) . VSMCs from SHRs have been shown to exhibit enhanced oxidative stress due to the overproduction of superoxide anion (O 2 ·Ϫ ) and enhanced activity of NADPH oxidase as well as the enhanced expression of Nox1/Nox2/Nox4 and p47 phox subunits of NADPH oxidase (19, 34) . We previously showed the implication of enhanced oxidative stress in enhanced expression of Gi␣ proteins in VSMCs from SHRs (2) . Taken together, it may be possible that the increased oxidative stress exhibited by VSMCs from SHRs may also be a contributing factor in enhanced expression of Gq␣ and PLC␤1 proteins and resultant hypertrophy. The present study is therefore undertaken to examine the role of oxidative stress in enhanced expression of Gq␣ and PLC␤1 proteins and hypertrophy in VSMCs from SHRs and to further explore the underlying mechanisms responsible for this response.
We showed that enhanced oxidative stress exhibited by VSMCs from SHRs activates c-Src, which through the transactivation of growth factor receptors and MAPK signaling contributes to enhanced expression of Gq␣/PLC␤1 proteins and resultant enhanced protein synthesis. Fig. 1 . Effect of N-acetyl-cysteine (NAC) and DPI, an inhibitor of NAD(P)H oxidase, on protein synthesis and Gq␣/PLC␤1 protein expression in vascular smooth muscle cells (VSMCs) from 16-wk-old spontaneously hypertensive rats (SHRs) and age-matched Wistar Kyoto (WKY) rats. VSMCs from 16-wk-old SHRs and age-matched WKY rats were incubated with NAC and DPI. The cell lysates were prepared and subjected to Western blotting using specific antibodies against Gq␣ and PLC␤1 (A and B, top) as described in MATERIALS AND METHODS. The ␤-actin was used as the loading control (CTL). The proteins were quantified by densitometric scanning (A 
MATERIALS AND METHODS

Materials.
Epidermal growth factor receptor (EGFR) inhibitor AG1478, platelet-derived growth factor receptor (PDGFR) inhibitor AG1295, insulin-like growth factor receptor 1 (IGF-1R) inhibitor AG1028, free radicals scavenger N-acetyl-cysteine (NAC), c-Src inhibitor PP2, inactive analog for Src inhibitor PP3, and inhibitor of NADPH oxidase DPI were purchased from Sigma-Aldrich Chemical (St. Louis, MO). Leucine, L-4,5-3H(N) was purchased from Perkin Elmer (Boston, MA). Monoclonal Gq␣ antibody (10), monoclonal PLC-␤1 antibody (D-8), monoclonal (phospho)-ERK1/2 (phosphospecific-tyrosine204) antibody, polyclonal ERK1/2 antibody (C-14), monoclonal dynein IC1/2 antibody (74-1), and Western blotting reagents were from St. Cruz Biotech (Santa Cruz, CA). Polyclonal (phospho)-EGFR antibody (phosphospecific-tyrosine1173) and polyclonal (phospho)-PDGFR (phosphospecific-tyrosine 857) were from Calbiochem. Polyclonal EGFR, IGF-1R, (phospho)-c-Src (phosphospecific-tyrosine-419), PDGFR, and (phospho)-IGF-1R (phosphospecific-tyrosine1165/1166) antibodies were from St. Cruz Biotech. Monoclonal anti-␤-actin antibody (A5441) and all other chemicals used in these experiments were purchased from Sigma-Aldrich (St. Louis, MO). Thermo Scientific Cellomics Whole Cell Stains was from fisher scientific.
Animals, cell culture, and incubation. VSMCs from 16-wk-old SHRs and age-matched Wistar Kyoto (WKY) rats were cultured as described previously (3) . These cells were plated in 75-cm 2 flasks and incubated at 37°C in 95% air-5% CO2 humidified atmosphere in DMEM (with glucose, L-glutamine, and sodium bicarbonate) containing 1% antibiotics (containing penicillin, streptomycin, and amphotrecin B) and 10% heat-inactivated FBS. Cells were passaged upon reaching confluence with 0.5% trypsin and used between passages 2 and 8. Confluent cells were starved by incubation for 24 h in DMEM without FBS at 37°C to have cell quiescence. For the receptor antagonist and antioxidant studies, VSMCs from SHRs and WKY rats were incubated for 16 h in the absence or presence of NAC (10 mM), DPI (5 M), AG1478 (5 M), AG1295 (5 M), AG1028 (5 M), PP2 (1 M), and PP3 (1 M). After incubation, the cells were washed twice with ice-cold PBS and lysed in a 200 l buffer containing 25 mM Tris·HCl (pH 7.5), 25 mM NaCl, 1 mM sodium orthovanadate, 10 mM sodium fluoride, 10 mM sodium pyrophosphate, 2 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, 1% Triton X-100, 0.1% sodium dodecyl sulfate, and 0.5 g/ml leupeptin on ice. The cell lysates were centrifuged at 12,000 g for 15 min at 4°C, and the supernatants were used for Western blot analysis. Cell viability was checked by the trypan blue exclusion technique and indicated that Ͼ90ϳ95% cells were viable. All the animal procedures used in the present study were approved by the Comité de Déontologie de l=Expérimentation sur les Animaux (CDEA) of the University of Montreal (No. 99050). The investigation conforms to the Guide for the Care and Use of Laboratory.
Western blotting. The levels of protein expression and phosphorylation were determined by Western blotting as described previously (4) . After SDS-PAGE, the separated proteins were transferred to a nitrocellulose membrane with a semi-dry transblot apparatus (BioRad Laboratories, Mississauga, Ontario, Canada) at 15 V for 45 min (Gq␣, c-Src, and ERK1/2) or a liquid transfer apparatus (Bio-Rad Laboratories) at 100 V for 1 h (PLC␤1, EGFR, IGF-1R, and PDGFR). Membranes were blocked for 1 h at room temperature with 5% dry milk and incubated overnight with specific antibodies against different proteins: (10) against Gq␣, (D-8) against PLC-␤1, E-4 against (phospho)-ERK1/2 (phosphospecific-tyrosine204) antibody, C-14 against ERK 1/2, phosphospecific Tyr 1173 against p-EGFR, 1005 against EGFR, phosphospecific Tyr 857 against pPDGFR, 958 against PDGFR, phosphospecific-tyrosine1165/1166 against pIGF-1R, C-20 against IGF-1R, phosphospecific-tyrosine-419 against pc-Src and 74-1 against dynein in PBS containing 0,1% Tween-20 overnight at 4°C. ␤-Actin or dynein was used as loading controls. The antibody-antigen complexes were detected by incubating the membranes with horseradish peroxidase-conjugated antibodies for 1 h at room temperature. The blots were then washed three times with PBS before reaction with enhanced chemiluminescence (ECL). Quantitative analysis of the proteins was performed by densitometric scanning of the autoradiographs using the enhanced laser densitometer LKB Ultroscan XL and quantified using the gel-scan XL evaluation software (version 2.1) from Pharmacia (Baie d=Urfé, Québec, Canada).
Transfection of VSMCs with small interfering RNA. For small interfering RNA (siRNA) transfection efficiency, the manufacturer's protocol was followed. Briefly, VSMCs were seeded in a 12-well plate or petri dishes and cultured in antibiotic free normal growth medium supplemented with 10% FBS until the cells were 60% confluent (ϳ48 h). On the day of transfection, cells were washed with transfection medium (sc-36868) and incubated with 1 ml of transfection reagent (sc-29528) containing 80 pmoles of either scrambled siRNA (sc-37007) or siRNA specific for c-Src or EGFR oligonucleotides for 12 h. The medium was replaced with normal DMEM (containing 10% FBS and 1% antibiotics) for an additional 24 h (90% confluence).
EGFR SiRNA (r) sc-108050 is a pool of three different siRNA duplexes according to the following sequences: Sc-108050A: Sense: GCUGUGCGAUUUAGCAACAtt; Antisense: UGUUGCUAAAUCGCACAGCtt. Sc-108050B: Sense: CAAGCCCA CUUGAGGAUAUtt; Antisense: AUAUCCUCAAGUGGGCUUGtt. Sc-108050C: Sense: GAAGAGACCUGCAUUAUCAtt; Antisense: UGAUAAUGCAGGUCUCUU Ctt. c-Src SiRNA (r) sc-270199 is a pool of two different siRNA duplexes according to the following sequences: sc-270199A: Sense: GAUCACUAGACGGGAAUCAtt; Antisense: UGAUUCCCGUCUAGUGAUCtt. Sc-270199B: Sense: GCUUACUACUCCAAAC AUGtt; Antisense: CAUGUUUGGAGUAGUAAGCtt. All sequences are provided in 5=-3= orientation.
Determination of protein synthesis. VSMCs from 16-wk-old SHRs and age-matched WKY rats were grown to confluence in 12-well culture plates. Protein synthesis (Cell hypertrophy) was evaluated by [ 3 H]-leucine incorporation into cells as described previously (32) . Confluent cells were serum deprived for 24 h to induce cell quiescence and were further incubated for 24 h in the absence or presence Fig. 4 . Effect of the knockdown of epidermal growth factor receptor (EGFR) on enhanced expression Gq␣/PLC␤1 proteins and enhanced protein synthesis in VSMCs from 16-wk-old SHRs and age-matched WKY rats. Confluent VSMCs from 16-wk-old SHRs and age-matched WKY rats were incubated in the absence or presence of EGFR-small interfering RNA (siRNA) for 12 h. A scramble siRNA was used as a negative control. Cell lysates were prepared and subjected to Western blot analysis using specific antibody against EGFR (A), Gq␣ (B), and PLC␤1 (C). The ␤-actin and dynein were used as the loading control. The protein bands were quantified by densitometric scanning (A, B, and C, bottom), and protein synthesis was determined by 3 H-leucine incorporation (D) as described in MATERIALS AND METHODS. Results are expressed as a percentage of control taken as 100%. Values are means Ϯ SE of 3 separate experiments using different cell cultures. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001 vs. WKY rats; #P Ͻ 0.05, ##P Ͻ 0.01 vs. SHRs.
3 H]-leucine (2Ci per well) was added at the same time as the inhibitors. For RNA interference studies, the cells were incubated in the absence or presence of siRNA against c-Src and EGFR. [ 3 H]-leucine was added and further incubated for 24 h before the cells were harvested. The cells were rinsed twice with ice-cold 1ϫ PBS and incubated with 5% TCA for 1 h at 4°C. After being washed twice with ice-cold 1ϫ PBS, the cells were incubated with 0.4 N sodium hydroxide solution for 30 min at room temperature, and radioactivity was determined by liquid scintillation counter and adjusted by protein concentration.
Cell volume measurement. VSMCs from 16-wk-old SHRs and age-matched WKY rats were grown to 50% confluence in cell imaging dish (35 ϫ 10 mm). Cells were serum deprived for 24 h to induce cell quiescence and were incubated for 16 h in the absence or presence of NAC (10 M) and DPI (5 M). The cells were then washed twice and fixed with 10% formalin for 1 h in 4°C and further incubated for 45 min at room temperature with whole cell stains reagent using Thermo Scientific Cellomics Whole Cell Stains (green). The volume of VSMCs was evaluated by three-dimensional live cell microscopy imaging by using Zeiss LSM-T-PMT 700 (Zen 2012), Objective Plan-Apochromat 63x/1.40 Oil DIC, and 40ϫ/1.40 Oil DIC. The three-dimensional microscopy datasets interpretation was performed with the software Imaris (Bitplane).
Statistical analysis. Results are expressed as means Ϯ SE. Comparisons between groups were made with one-way ANOVA followed by Bonferroni's post hoc test. A difference between groups was significant at P Ͻ 0.05.
RESULTS
Implication of oxidative stress in enhanced expression of
Gq␣/PLC␤1 proteins and enhanced protein synthesis. We have earlier shown that VSMC from SHR exhibit enhanced expression of Gq␣ and PLC␤1 proteins that contribute to VSMC hypertrophy (4). Because VSMCs from SHRs have been shown to exhibit enhanced oxidative stress due to the enhanced levels of superoxide anion (O 2 ·Ϫ ) and NADPH oxidase activity (40) , it was of interest to examine if the enhanced oxidative stress contributes to the enhanced expression of Gq␣ and PLC␤1 proteins and enhanced protein synthesis in VSMC from SHR. To test this, the effect of antioxidant DPI, an inhibitor of NADPH oxidase and N-acetylcysteine (NAC), free radical scavenger, on the expression of Gq␣ and PLC␤1 proteins and protein synthesis was examined. Results shown in Fig. 1 indicate that DPI (5 M) and NAC (10 mM) decreased significantly the enhanced expression of Gq␣ by about 45% (Fig. 1A) and the enhanced expression of PLC␤1 protein by 30% and 40%, respectively (Fig. 1B) . In addition, the enhanced protein synthesis was almost completely abol- ished by these treatments in VSMCs from SHRs (Fig. 1C) . Furthermore, DPI was effective in reducing significantly the protein synthesis in VSMCs from WKY rats by about 45% (Fig. 1C) .
We also determined the effect of NAC and DPI on cell volume, another marker of VSMC hypertrophy and the results are shown in Fig. 2 interest to examine the contribution of growth factor receptor in enhanced protein synthesis and enhanced expression of Gq␣ and PLC␤1 proteins. To investigate this, the effects of AG1478, an inhibitor of EGFR; AG1295, an inhibitor of PDGFR; and AG1024, an inhibitor of IGF-1R were assessed on the expression of Gq␣ and PLC␤1 proteins in VSMCs from SHRs and WKY rats, and the results are shown in Fig. 3 . The enhanced expression of Gq␣ proteins (Fig. 3A) in VSMCs from SHR was completely restored to the control WKY levels by AG1478, AG1295, and AG1024, whereas these inhibitors attenuated the enhanced expression of PLC␤1 by about 70%, 75%, and 90%, respectively (Fig. 3B) . On the other hand, these inhibitors did not have any significant effect on the expression of Gq␣ or PLC␤1 proteins in VSMC from WKY rats. In addition, AG1478, AG1295, and AG1028 also attenuated significantly the enhanced protein synthesis by about 45%, 60%, and 75%, respectively, in VSMCs from SHRs, whereas these inhibitors did not have any significant effect on the protein synthesis in VSMCs from WKY rats (Fig. 3C) .
We also used siRNA of EGFR to confirm its role in enhanced expression of Gq␣ and PLC␤1 proteins and associated enhanced protein synthesis in VSMCs from SHRs, and the results are shown in Fig. 4 . The expression of EGFR was significantly enhanced by about 125% in VSMCs from SHRs as compared with WKY rats. Treatment of VSMCs with EGFR-siRNA that attenuated the expression of EGFR in VSMCs from SHRs by about 85% (Fig. 4A ) also resulted in a significant attenuation of enhanced expression of Gq␣ (Fig.  4B) and PLC␤1 (Fig. 4C) proteins by about 60% and 65%, respectively, and enhanced protein synthesis by about 45% in VSMCs from SHRs (Fig. 4D) . In addition, EGFR-siRNA also attenuated the expression of Gq␣ by about 45% in VSMC from WKY rats (Fig. 4B) .
Implication of oxidative stress in enhanced expression and phosphorylation of growth factor receptors in VSMCs from
SHRs. Because growth factor receptors and enhanced oxidative stress contribute to the enhanced expression of Gq␣ and PLC␤1 proteins in VSMCs from SHRs, it was desirable to examine whether increased oxidative stress contributes to the enhanced expression and activation of growth factor receptor in VSMCs from SHRs. To test this, the effects of NAC and DPI were evaluated on the expression and phosphorylation of growth factor receptors in VSMCs from SHRs and WKY rats. As shown in Fig. 5 , the increased phosphorylation of EGFR (Fig. 5A) , IGF-1R (Fig. 5C ), and PDGFR (Fig. 5E ) was diminished by NAC and DPI toward WKY levels. Furthermore, the phosphorylation levels of IGF-1R and PDGFR were also significantly decreased by these antioxidants in VSMCs from WKY rats. In addition, the expression of EGFR (Fig. 5B ) and IGF-1R (Fig. 5D) but not of PDGFR was increased in VSMCs from 16-wk-old SHRs as compared with WKY rats by about 200% and 150%, respectively; both these antioxidants NAC and DPI attenuated the enhanced expression of EGFR by about 65% and 80%, respectively, whereas the enhanced expression of IGF-1R was completely abolished by these antioxidants. Furthermore, the protein expression of IGF-1R in VSMCs from WKY rats was also significantly decreased (Ϸ70%) by NAC.
Implication of c-Src in enhanced expression of Gq␣/PLC␤1 proteins and protein synthesis in VSMCs from
SHRs. Because c-Src has been reported to be activated by ROS in VSMCs (12) , it was of interest to examine whether c-Src is also implicated in oxidative stress-induced enhanced expression of Gq␣/PLC␤1 proteins and enhanced protein synthesis in VSMCs from SHRs. To investigate this, we examined the effect of PP2, an inhibitor of c-Src on the enhanced expression of Gq␣ and PLC␤1 proteins and enhanced protein synthesis. Results shown in Fig. 6 indicate that treatment of cells with PP2 but not PP3, an inactive analog of PP2, almost completely attenuated the enhanced expression of Gq␣ protein (Fig. 6A) , whereas the enhanced expression of PLC␤1 protein (Fig. 6B ) and enhanced protein synthesis (Fig. 6C) were attenuated by about 75% and 80%, respectively, in VSMCs from SHRs. On the other hand, PP2 and PP3 did not have any effect on the expression of Gq␣ and PLC␤1 proteins in VSMCs from WKY rats; however, PP2 and not PP3 inhibited the protein synthesis in WKY rats by about 20%.
To further confirm the role of c-Src molecule in enhanced expression of Gq␣ and PLC␤1 proteins and enhanced protein synthesis in VSMCs from SHRs, we tested the effect of c-Src specific siRNA on the enhanced levels of Gq␣ and PLC␤1 protein and associated hypertrophy in VSMCs from SHRs and the results are shown in Fig. 7 . Treatment of VSMCs with c-Src siRNA that attenuated significantly the expression of c-Src in both VSMCs from SHRs and WKY rats by about 35% and 50% (Fig. 7A) , respectively, resulted in a significant attenuation of enhanced expression of Gq␣ (Fig. 7B) and PLC␤1 (Fig. 7C) proteins by about 75% and 90%, respectively, and enhanced protein synthesis by about 60% (Fig. 7D) in VSMCs from SHRs. In addition, the expression of Gq␣ protein (Fig. 7B ) and the protein synthesis (Fig. 7D) in VSMCs from WKY rats were also significantly decreased.
Implication of oxidative stress in enhanced phosphorylation of c-Src in VSMCs from SHRs.
To determine whether the activation of growth factor receptors by oxidative stress occurs directly or through c-Src activation, the effect of NAC and DPI was assessed on the phosphorylation of c-Src at tyrosine 419 (Tyr 419 ) in VSMCs from SHRs and WKY rats. As shown in Fig. 8 , the increased phosphorylation of c-Src at Tyr 419 (85%) was attenuated by NAC (10 mM) and DPI (5 M) toward WKY levels, whereas it did not have any significant effect in VSMCs from WKY rats. Furthermore, the expression level of total c-Src molecule was not altered in VSMCs from SHRs as compared with WKY rats, and NAC and DPI did not affect the expression level of c-Src.
Implication of c-Src in enhanced expression and phosphorylation of growth factor receptors in VSMCs from SHRs. To determine whether c-Src is the upstream signaling molecule and contributes to the activation of growth factor receptors, the effect of c-Src inhibitor PP2 and PP3, an inactive analog of PP2, was assessed on the phosphorylation of growth factor receptors in VSMCs from SHRs and WKY rats. As illustrated in Fig. 9 , PP2, but not PP3, attenuated the enhanced phosphorylation of EGFR (Fig. 9A) , IGF-1R (Fig. 9C) , and PDGFR (Fig. 9E) in VSMCs from SHRs to WKY control levels. In addition, the enhanced expression of EGFR (Fig. 9B) and IGF-1R (Fig. 9D) in VSMCs from SHRs was also attenuated by PP2 by about 40% and 90%, respectively; however, PP2 or PP3 did not have any effect on the phosphorylation and expression levels of growth factor receptors in VSMCs from WKY rats.
Implication of oxidative stress and c-Src in MAP kinase signaling in VSMCs from SHRs. We earlier showed the implication of MAP kinase in enhanced protein synthesis in VSMCs from SHRs (4) as well as in ANG II-induced enhanced protein synthesis in A10 VSMCs (32) . Growth factor receptors signal through MAP kinase pathway (26, 36) . Because oxidative stress through c-Src transactivate growth factor receptors, it was desirable to examine the implication of ROS and c-Src in the activation of MAPK signaling. To test this, we examined the effect of NAC, DPI, and PP2 on the ERK1/2 phosphorylation in VSMCs from SHRs and WKY rats. Results shown in Fig. 10A indicate that ERK1/2 phosphorylation was significantly enhanced in VSMCs from SHRs as compared with WKY rats. Treatment with DPI attenuates the ERK1/2 phosphorylation in both VSMCs from SHRs and WKY rats; however, the enhanced phosphorylation of ERK1/2 was completely abolished in VSMCs from SHRs, whereas about 50% inhibi- tion was observed in WKY rats. On the other hand, NAC attenuated only slightly the enhanced ERK1/2 phosphorylation in VSMCs from SHRs. In addition, PP2 but not PP3 attenuated completely the enhanced phosphorylation of ERK1/2 in VSMCs from SHRs, whereas about 35% inhibition was observed in WKY rats (Fig. 10B) .
DISCUSSION
The implication of ROS in cardiomyocytes and VSMC hypertrophy has been shown by several studies (20, 39, 45) . In addition, a role of oxidative stress in the enhanced expression of Gq␣ and PLC␤ proteins in A10 VSMC exposed to high glucose and aortic VSMCs from STZ-diabetic rats has been shown (14) . We earlier showed that the enhanced levels of endogenous ANG II and ET-1 in VSMCs from 16-wk-old SHRs contribute to the enhanced expression of Gq␣ and PLC␤1 proteins and resultant increased protein synthesis through the activation of MAP kinase signaling (4) . In the present study, we report that enhanced oxidative stress contributes to the enhanced expression of Gq␣ and PLC␤1 proteins and VSMC hypertrophy in VSMCs from SHRs.
The fact that NAC and DPI that have been shown to restore the enhanced levels of ROS production (30, 44) also restored the enhanced expression of Gq␣, PLC␤1 proteins, enhanced protein synthesis, and increased cell volume, markers of VSMC hypertrophy in SHRs suggests the implication of ROS in enhanced expression of Gq␣ and PLC␤ proteins as well as VSMC hypertrophy in SHRs. In this regard, VSMCs from SHRs have been shown to exhibit enhanced oxidative stress due to the overproduction of O 2 ·Ϫ , enhanced activity, and overexpression of Nox1/Nox2/Nox4 and p47 phox subunits of NADPH oxidase (19, 40) . However, Nox5 that has been shown to be expressed in several tissues including human endocardial cells, human VSMCs, and human endothelial cells (1) does not appear to contribute to enhanced oxidative stress in VSMCs from SHRs because Nox5 is expressed only in primates and not in rodents (28) . In addition, a role of NAD(P)H oxidase-derived ROS in potentiating Ang IIinduced VSMC hypertrophy and in exacerbating larges arteries remodeling has also been shown (45) . In addition, NAC was shown to reduce pulmonary vascular remodeling and left ventricular hypertrophy induced by monocrotaline (11) . Furthermore, NOX2 was also implicated in ANG II-induced cardiomyocyte hypertrophy (21) .
The underlying mechanism by which ROS enhanced the expression of Gq␣ and PLC␤ proteins in VSMCs from SHRs appears to involve the transactivation of growth factor receptors, because the enhanced phosphorylation of growth factor receptors exhibited by VSMCs from SHRs was attenuated by both NAC and DPI. In this regard, a role of oxidative stress in the transactivation of growth factor receptors has been reported (5, 37). Our results showing that the inhibition of growth factor receptor tyrosine kinase that phosphorylate the receptors by specific inhibitors AG1478, AG1295, and AG1024 and the downregulation of EGFR by siRNA that attenuated significantly the enhanced expression of Gq␣ and PLC␤1 proteins and enhanced protein synthesis in VSMCs from SHRs suggest the implication of both the expression and activation of growth factor receptors in enhanced expression of Gq␣ and PLC␤1 proteins and enhanced protein synthesis in these cells. These results are consistent with our earlier studies showing a role of growth factor receptors in the enhanced expression of Gi␣ proteins and hyperproliferation of VSMCs from SHRs (17, 33) . In addition, ET-1 was also shown to enhance the expression of Gi␣ proteins and proliferation through the transactivation of EGFR in A 10 VSMC (18) . Furthermore, a role of growth factor receptors in VSMC hypertrophy has also been shown by several studies (7, 9, 10) . Bouallegue et al. (10) demonstrated the implication of IGF-1R in ET-1 and ANG II-induced VSMC hypertrophy. In addition, in vivo treatment with AG1478 was also shown to attenuate ANG II-induced vascular hypertrophy (7). Furthermore, Kagiyama et al. (24, 25) have shown the implication of EGFR in ANG II and hypertension (SHR)-induced left ventricular hypertrophy by using antisense oligodeoxynucleotide to EGFR (EGFR-AS).
We demonstrate for the first time an enhanced expression of EGFR and IGF-1R in VSMCs from SHRs in 16-wk-old SHRs, which may be linked to VSMC dedifferentiation in this animal model of essential hypertension. The enhanced levels of EGFR protein were shown in several diseases such as ovarian carcinomas and primary human brain tumor (27, 35, 46) . ANG II that induces VSMC hypertrophy was also reported to increase the expression of IGF-1R (15, 41) .
We also demonstrate that c-Src inhibitor PP2 and siRNA attenuated the enhanced expression of Gq␣ and PLC␤ proteins and enhanced protein synthesis to WKY levels suggest the role of c-Src in enhanced expression of Gq␣ and PLC␤ proteins and enhanced protein synthesis. Our results are consistent with the studies of Descorbeth and Anand-Srivastava, who have also reported the implication of c-Src in the enhanced expression of Gq␣ and PLC␤ induced by high glucose in A10 VSMC (13) as well as in the enhanced expression of Gi␣ proteins in VSMCs from SHRs (17) . In addition, we also report that oxidative stress is the upstream signaling molecule of c-Src because of the fact that NAC and DPI attenuated the enhanced phosphorylation of c-Src in VSMCs from SHRs. In this regard, the contribution of oxidative stress in c-Src activation has also been shown previously in VSMCs from SHRs (17, 33) . Furthermore, the activation of c-Src by H 2 O 2 in VSMCs has also been reported (5, 9, 37) . We also report that PP2, a c-Src inhibitor, attenuated the enhanced expression and phosphorylation of growth factor receptors as well as enhanced phosphorylation of ERK1/2 to control WKY levels and suggests that c-Src is upstream of growth factor receptor activation. Taken together, it may be suggested that oxidative stress, through the activation of c-Src, transactivate growth factor receptors and results in the activation of ERK1/2, which contributes to the enhanced expression of Gq␣ and PLC␤1 proteins and resultant VSMC hypertrophy. In this regard, a role of MAPK in enhanced expression of Gq␣/PLC␤1 proteins and enhanced protein synthesis in VSMCs from SHRs has been shown (4). The role of oxidative stress in enhanced activation of ERK1/2 in VSMCs from SHRs has also been shown (31) . In addition, H 2 O 2 was shown to activate ERK1/2 in an EGF-R/ c-Src-dependent fashion (37) .
In summary, we provide the first direct evidence that the enhanced oxidative stress exhibited by VSMCs from SHRs activates c-Src, which through the activation of growth factor receptor and MAP kinase signaling increases the expression of Gq␣ and PLC␤1 proteins and results in hypertrophy (Fig. 11) . From these studies, it may be suggested that G q ␣ and PLC-␤1 proteins may be used as the potential targets for the development of new therapies for the treatment of cardiovascular diseases.
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